Form 4 for WHWK Whitehawk Therapeutics, Inc.
Accepted 2026-04-10 18:46:06 ET · period of report 2026-04-09 · accession 0001995275-26-000012 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-04-10 18:46 | 2026-04-09 | WHWK | Lennon David James | CEO, Dir | S - Sale | $3.38 | -14.5K | 518.6K | -3% | -$49.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-04-09 | S | D | 14,500 | $3.38 | 518,622 | D | — | — | (F1) Represents a broker-assisted sale to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of restricted stock units. |